Abstract:Objective To investigate the causes of high-demand blood transfusion during perioperative period of patients with esophagus cancer, and to analyze the effect of high-demand blood transfusion on postoperative recovery and related biochemical indicators. Methods A stratified cluster sampling method was used to select 58 patients with esophageal cancer admitted to the Department of Thoracic Surgery of the First Hospital of Jiaxing from May 2017 to December 2018, with 29 patients with blood transfusion volume ≥1000 mL during the perioperative period of esophageal cancer resection were divided into the observation group, and 29 patients with blood transfusion volume <1000 mL were divided into the control group, the causes and effects of high-demand blood transfusion (blood transfusion volume ≥1000 mL) were analyzed, with the length of stay in the intensive care unit, length of hospital stay, complication rate after esophageal cancer resection, platelet count and blood potassium and calcium levels included. Results The complication rate of the observation group (62.1%) was higher than that of the control group (31.0%), and the difference was statistically significant (P < 0.05). The blood loss during resection of esophageal cancer in the observation group was higher than that in the control group, while the length of stay in the intensive care unit and hospital stay were both longer than those in the control group, and the differences were all statistically significant (all P < 0.05). After blood transfusion, the platelet count of the observation group was lower than that of the control group, and the difference was statistically significant (P < 0.05). After blood transfusion, the blood potassium and calcium levels of the observation group were lower than those of the control group, and the differences were all statistically significant (all P < 0.05). Conclusion The main reason for the high-demand blood transfusion during perioperative period of esophageal cancer resection in patients with esophageal cancer is intraoperative bleeding. High-demand blood transfusion can lead to enhanced postoperative coagulation function and the incidence of complications after esophageal cancer resection will increase.
陈涛 王雪春 顾学红 于琴. 高需求输血对食管癌切除术后恢复及相关生化指标变化的影响[J]. 中国医药导报, 2021, 18(2): 98-101.
CHEN Tao WANG Xuechun GU Xuehong YU Qin. Effect of high-demand blood transfusion on postoperative recovery of esophageal cancer and changes in related biochemical indicators. 中国医药导报, 2021, 18(2): 98-101.
[1] 鞠燕鹏.无痛内镜精细筛查提高消化道肿瘤的高危人群诊断率的临床价值分析[J].临床医药文献电子杂志,2018, 5(74):170-171.
[2] 李洁平,李俊娥,罗世伟.外伤患者大量输血后对电解质、凝血功能及免疫功能的影响研究[J].中国实验诊断学,2018,22(1):70-72.
[3] 刘璇,陈麟凤,庄健美,等.除输血不良反应外临床用血相关不良事件分析[J].中华医学杂志,2019,99(6):438-441.
[4] 国家卫生健康委员会.食管癌诊疗规范(2018年版)[J].中华消化病与影像杂志:电子版,2019,9(4):158-192.
[5] 卢姗姗,李秀英.《临床输血技术规范》(2000年版)改进必要性探讨[J].国际输血及血液学杂志,2015,38(4):367-369.
[6] 黄晓峰,刘理礼,陈肖红,等.肠内营养治疗在消化道肿瘤患者化疗过程中的应用研究[J].贵州医药,2018,42(8):83-85.
[7] Zhao H,Diao C,Wang X,et al. LncRNA BDNF-AS inhibits proliferation,migration,invasion and EMT in oesophageal cancer cells by targeting miR-214 [J]. J Cell Mol Med,2018,22(8):3729-3739.
[8] 李建军,许志峰,崔芬,等.完全内脏转位合并肠道肿瘤的诊断与治疗并文献复习[J].中华诊断学电子杂志,2018,6(1):61.
[9] Stethen TW,Ghazi YA,Heidel RE,et al. Walking to recovery:the effects of missed ambulation events on postsurgical recovery after bowel resection [J]. J Gastro Oncol,2018,9(5):953-961.
[10] 梅礼军,陈葳.输血患者不良反应的临床特点及其相关影响因素分析[J].国外医学医学地理杂志,2017,38(1):45-47.
[11] Thrumurthy SG,Chaudry MA,Thrumurthy SSD,et al. Oesophageal cancer:risks,prevention,and diagnosis [J]. BMJ,2019,366(12):229-234.
[12] 韦兰,张艳梅.常规凝血检验项目对异位妊娠大出血输血治疗不良反应监测的价值评价[J].现代诊断与治疗,2017,28(4):601-603.
[13] Yu C,Tang H,Guo Y,et al. Effect of Hot Tea Consumption and Its Interactions With Alcohol and Tobacco Use on the Risk for Esophageal Cancer:A Population-Based Cohort Study [J]. Ann Intern Med,2018,168(7):128-132.
[14] 马荣,弓磊,尚晓滨,等.腔镜食管癌根治术与开放三切口食管癌根治术的疗效分析[J].中华消化外科杂志,2018,17(8):804-809.
[15] 刘丹丹,孙惠杰,赵丹丹,等.食管癌的诊断及治疗进展[J].癌症进展,2018,16(7):804-806.
[16] Liu J,Chen S,Chen Y,et al. Perioperative blood transfusion has no effect on overall survival after esophageal resection for esophageal squamous cell carcinoma:A retrospective cohort study [J]. Int J Surg,2018,22(1):223-226.
[17] 耿小红.上消化道出血患者输血治疗及其疗效评估[J].世界最新医学信息文摘,2017,1(62):151-152.
[18] Cao YY,Yu J,Liu TT,et al. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling [J]. Cell Death Dis,2018,9(2):129-134.
[19] 戴玥,涂秋华.血型实验室输血检验的质量控制与输血安全探析[J].中西医结合心血管病电子杂志,2017,5(30):101.
[20] Samson P,Puri V,Lockhart AC,et al. Adjuvant Chemotherapy for Pathologic Node Positive Esophageal Cancer Patients Following Induction Chemotherapy is Associated with Improved Survival [J]. J Thorac Cardiov Sur,2018, 156(4):557-561.
[21] 王康,王长奇,欧阳福桂,等.大量输血方案在大出血和凝血病早期的应用研究[J].重庆医学,2017,46(10):1352-1354.
[22] Sakai M,Sohda M,Miyazaki T,et al. Association of Preoperative Nutritional Status with Prognosis in Patients with Esophageal Cancer Undergoing Salvage Esophagectomy [J]. Anticancer Res,2018,38(2):933-938.